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Introduction
Over the past 5 years, several interventions have been
shown in randomized clinical trials (RCTs) to reduce
mortality in patients with ARDS. The current use of
these interventions in clinical practice, along with those
of unproven benefit, is unknown.
Objectives
To determine which ventilation strategies and adjunctive
treatments clinicians use for moderate-severe ARDS,
and which ones they use as rescue therapy in refractory
hypoxemia.
Methods
We conducted a 12-month observational study (2014/03-
2015/02) in 23 Canadian and 1 Saudi Arabian intensive
care units (ICUs) that had participated in the OSCILLATE
RCT of high frequency oscillation (HFO). We included
mechanically ventilated adults with moderate-severe
ARDS (Berlin criteria), defined by PaO2/FiO2 ≤200 with
positive end-expiratory pressure (PEEP) ≥5 cmH2O, and
who also required a FiO2 ≥0.50. Consecutive patients were
prospectively identified and we collected baseline demo-
graphics, daily ventilation settings and adjunctive therapies
for ARDS up to ICU day 28, and hospital outcomes.
Results
These preliminary results include data from 533 patients.
On day 1 of ARDS diagnosis, the most common ventila-
tor modes were pressure control (n = 222, 42%) and
volume control (n = 123, 23%). The mean FiO2 was 0.74
(SD = 0.21), tidal volume 7.4 ml/kg (SD = 2.2) predicted
body weight (PBW), plateau pressure 26 (SD = 7) cmH2O
and PEEP 11 (SD = 4) cmH2O. One-third of patients
(155/466) were ventilated with tidal volume >8ml/kg PBW
on day 1. In all patients, the most common respiratory
adjuncts used were neuromuscular blocking agents
(NMBA) (n = 204, 38%), corticosteroids (n = 139, 26%),
pulmonary vasodilators (n = 88, 17%), prone positioning
(n = 48, 9%), HFO (n = 24, 5%) and extracorporeal life
support (ECLS) (n = 23, 4%). Among 82 patients with
refractory hypoxemia, defined as a sustained PaO2 ≤60
mmHg on FiO2 1.0, use of adjuncts increased: NMBA
(n = 52, 63%), pulmonary vasodilators (n= 39, 48%), corti-
costeroids (n = 26, 32%), prone positioning (n = 21, 26%),
HFOV (n = 14, 17%) and ECLS (n = 10, 12%). Median
length of mechanical ventilation was 9 (IQR = 4, 17) days
and ICU length of stay was 11 (IQR = 6, 20) days. ICU
mortality was 46% (225/491) overall, and higher (63%,
49/78) among patients with refractory hypoxemia. With-
drawal of life support preceded 36% of deaths (n = 80).
Conclusions
Clinicians generally utilized low tidal volume ventilation,
although in many patients the recommended threshold
was exceeded. Initial PEEP levels were lower than those
used in high PEEP arms of several RCTs. HFOV was
used infrequently in these centres. The most common
respiratory adjunct was NMBAs. Despite stronger RCT
evidence to support prone positioning, it was employed
infrequently.
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